The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the seizure of nearly 20 million counterfeit erectile dysfunction tablets in the United Kingdom over the last five years. This alarming statistic underscores the growing threat posed by illegal online sales of these medications, which are often marketed to exploit the stigma surrounding erectile dysfunction.
Between 2021 and 2025, the MHRA’s criminal enforcement unit confiscated approximately 19.5 million illegal doses of drugs claiming to assist with erectile dysfunction. Notably, 4.4 million of these pills were seized in 2025 alone. The agency warns that many of these products contain no active ingredients, incorrect dosages, or even harmful substances.
Health Risks Associated with Counterfeit Medications
Andy Morling, head of the MHRA’s criminal enforcement unit, emphasized the dangers of purchasing unauthorized medications. He stated, “Stigma and embarrassment are being exploited by criminals selling fake medicines that can seriously harm your health.” Morling highlighted the risks individuals face when they purchase unregulated products, noting that many pills may appear genuine but can contain dangerous elements.
The MHRA’s data indicates that the annual seizures of illegal erectile dysfunction pills have more than doubled since 2022. The agency is actively combating this issue by collaborating with internet service providers to disrupt illegal online sales. In 2025, the MHRA successfully targeted over 1,500 websites and social media accounts involved in the sale of counterfeit medical products and removed more than 1,200 social media posts promoting these illegal items.
Public Awareness and Safety Measures
The MHRA is urging men to be cautious about online purchases of erectile dysfunction medications, stressing that any medicine not authorized for sale in the UK can be unsafe or ineffective. The agency encourages individuals to consult healthcare professionals for legitimate treatments.
As the illegal market for erectile dysfunction medicines continues to grow, the MHRA remains committed to protecting public health. The agency’s enforcement actions and public awareness campaigns aim to reduce the risks associated with counterfeit medications and ensure that men can access safe and effective treatments.
For more information on the dangers of counterfeit medications and how to stay safe, the MHRA encourages individuals to visit their official website or consult with a healthcare provider.
